Legal Cannabis Market Segments - by Product Type (Cannabis Flower, Concentrates, Edibles, Topicals, Pre-rolls), Application (Recreational, Medical), Distribution Channel (Dispensaries, Online Stores, Pharmacies, Supermarkets/Hypermarkets, Others), Ingredient Type (THC-dominant, CBD-dominant, Balanced THC/CBD, Others), and Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2025-2035

Legal Cannabis

Legal Cannabis Market Segments - by Product Type (Cannabis Flower, Concentrates, Edibles, Topicals, Pre-rolls), Application (Recreational, Medical), Distribution Channel (Dispensaries, Online Stores, Pharmacies, Supermarkets/Hypermarkets, Others), Ingredient Type (THC-dominant, CBD-dominant, Balanced THC/CBD, Others), and Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2025-2035

Legal Cannabis Market Outlook

The global legal cannabis market is projected to reach approximately USD 73.6 billion by 2025, growing at a CAGR of about 26.7% from 2025 to 2035. The increasing acceptance of cannabis for medical and recreational use, along with the growing number of jurisdictions legalizing its use, is significantly contributing to the market's expansion. Moreover, the rising demand for cannabis-based products, such as CBD oils, edibles, and topicals, is driving innovation and product development in the sector. The changing perceptions towards cannabis consumption, fueled by ongoing research into its medicinal benefits, further enhances market growth. Additionally, the potential for lucrative investments in cannabis-related businesses is attracting both established companies and new entrants, heightening the competitive landscape.

Growth Factor of the Market

Several factors are driving the rapid growth of the legal cannabis market. Firstly, increasing legalization across various regions and countries has opened up new markets, allowing businesses to explore opportunities previously restricted due to legal challenges. Additionally, the growing body of research supporting the medical benefits of cannabis, particularly in pain management, anxiety, and epilepsy treatment, is attracting a wider consumer base. Furthermore, the growing trend of wellness and self-care has led to heightened interest in cannabis-derived products, especially those infused with CBD, which is recognized for its therapeutic effects without the psychoactive properties of THC. The expansion of the e-commerce sector has also made cannabis products more accessible to consumers, contributing to higher sales and consumption. Lastly, the rising acceptance of cannabis in mainstream culture has normalized its use, further fueling demand.

Key Highlights of the Market
  • Rapid growth in legal cannabis markets, with more countries and states legalizing its use for medical and recreational purposes.
  • Increased consumer awareness regarding the health benefits of cannabis, driving demand for medicinal products.
  • Diverse range of cannabis products available, including flowers, edibles, and topicals, catering to various consumer preferences.
  • Expansion of distribution channels, particularly online sales, providing greater accessibility to products.
  • Significant investments from both private and public sectors into cannabis research, technology, and product development.

By Product Type

Cannabis Flower:

Cannabis flower, which refers to the raw, unprocessed buds of the cannabis plant, remains one of the most popular product types in the legal cannabis market. It is typically consumed through smoking or vaporization, appealing to both recreational and medicinal users. The growth in the cannabis flower segment can be attributed to its traditional use and the wide variety of strains available, each offering different flavors, aromas, and effects. Furthermore, the market is witnessing innovations in cultivation techniques and genetics, which enhance the potency and quality of the flower. As a result, cannabis flower continues to dominate sales, particularly in regions where smoking remains the preferred consumption method.

Concentrates:

Concentrates are products derived from cannabis that contain high levels of cannabinoids, primarily THC or CBD, obtained through extraction methods. This segment includes products such as oils, waxes, and shatter, which are gaining significant traction due to their potency and versatility. Concentrates are often used in dabbing or vaporizing, providing users with a more intense experience. The growth of this segment is driven by the increasing sophistication of extraction technologies, which enable the production of higher-quality concentrates with minimal impurities. Additionally, as consumers look for more efficient ways to consume cannabis, concentrates are becoming a popular choice for both recreational and medicinal users.

Edibles:

The edibles segment encompasses a wide array of cannabis-infused food and beverage products, including gummies, chocolates, and drinks. The popularity of edibles is largely attributed to their discreet nature and the absence of smoke, making them an appealing option for consumers who may be sensitive to inhalation methods. Edibles provide longer-lasting effects compared to smoking, which attracts users seeking prolonged relief from conditions such as chronic pain or anxiety. The market for edibles is rapidly expanding as manufacturers experiment with diverse flavors and formulations, catering to different dietary preferences and needs. Moreover, as regulatory frameworks become more accommodating, the availability of cannabis edibles is expected to increase significantly.

Topicals:

Topicals are cannabis-infused products designed for external use, including creams, balms, and lotions. This segment is primarily driven by the therapeutic benefits of cannabinoids in treating localized pain, inflammation, and skin conditions. The appeal of topicals lies in their non-psychoactive nature, allowing users to experience the benefits of cannabis without the intoxicating effects associated with other consumption methods. As public awareness of the health benefits of cannabis continues to grow, the demand for topicals is expected to rise. Furthermore, innovations in formulation and application methods are enhancing the efficacy and experience of topical cannabis products.

Pre-rolls:

Pre-rolls are pre-rolled joints that provide a convenient way for consumers to enjoy cannabis without the need for preparation. This product type appeals particularly to new users and those seeking convenience as it eliminates the need for rolling, measuring, and packing. The popularity of pre-rolls has surged due to their affordability and variety, with many dispensaries offering pre-rolls made from various strains, blends, and infused options. Additionally, the rise of social consumption venues and events has boosted the demand for pre-rolls, as they are a popular choice for shared experiences among groups. As the market matures, pre-rolls are expected to remain a staple product for cannabis consumers.

By Application

Recreational:

The recreational application of cannabis pertains to its use for enjoyment and leisure, attracting a broad demographic of users. As recreational cannabis becomes legal in more jurisdictions, the market for recreational products is experiencing substantial growth. This segment benefits from increased consumer experimentation with various product types, including flower, edibles, and concentrates. Recreational users often seek products that enhance social experiences or provide relaxation and stress relief. The cultural shift towards normalization and acceptance of cannabis consumption has further fueled this growth, making it an integral part of social and entertainment experiences, particularly in locations where cannabis consumption is legally permitted.

Medical:

Medical cannabis is utilized for therapeutic purposes, treating a range of conditions such as chronic pain, anxiety, epilepsy, and multiple sclerosis. The demand for medical cannabis is driven by the increasing body of research supporting its efficacy, leading to greater acceptance among healthcare professionals and patients alike. As more countries and states implement medical cannabis programs, the market is poised for robust growth. Patients are increasingly seeking alternatives to traditional pharmaceuticals, and cannabis provides a viable option for many looking for natural remedies. Furthermore, the growing development of specialized formulations tailored for specific medical conditions is expanding the medical cannabis market, catering to the unique needs of patients.

By Distribution Channel

Dispensaries:

Dispensaries remain the primary distribution channel for legal cannabis products, providing consumers with direct access to a wide range of products. These establishments are often segmented into medical and recreational categories, allowing consumers to choose based on their specific needs. Dispensaries offer knowledgeable staff who can assist customers in selecting products that suit their preferences and requirements, enhancing the overall shopping experience. As the number of licensed dispensaries increases, competition among them intensifies, leading to improvements in customer service and product variety. Furthermore, many dispensaries are adopting innovative retail strategies, such as loyalty programs and educational workshops, to attract and retain customers.

Online Stores:

The rise of e-commerce has significantly impacted the legal cannabis market, with online stores providing consumers with convenient access to a broad assortment of cannabis products. This distribution channel appeals to a growing segment of tech-savvy consumers who prefer the privacy and convenience of shopping from home. Online stores often provide detailed product information, reviews, and user-generated content, aiding consumers in making informed purchasing decisions. Delivery services are also gaining traction, further enhancing the appeal of online shopping. However, regulatory restrictions and shipping limitations may pose challenges for online cannabis retailers, necessitating compliance with local laws and regulations.

Pharmacies:

Pharmacies are increasingly becoming recognized as legitimate distribution channels for medical cannabis products. This shift is primarily due to the growing acceptance of cannabis as a treatment option for various medical conditions. Pharmacies offer a regulated environment, thereby providing consumers with confidence regarding product safety and quality. Pharmacists can provide guidance on proper usage and dosage, ensuring that patients receive the most suitable treatment. However, the extent of pharmacy involvement in cannabis sales varies significantly by region, influenced by local laws and regulations governing the sale of cannabis products. As acceptance continues to grow, pharmacies are likely to play a larger role in the distribution of medical cannabis.

Supermarkets/Hypermarkets:

Supermarkets and hypermarkets are gradually starting to embrace the sale of cannabis products, particularly CBD-infused items, as consumer demand rises. This distribution channel capitalizes on the established infrastructure of these retail giants, allowing cannabis products to reach a broader audience. The convenience of purchasing cannabis alongside everyday grocery items simplifies the shopping experience for consumers. However, the integration of cannabis products into mainstream retail faces regulatory challenges and requires careful compliance with local laws. As perceptions of cannabis continue to evolve, supermarkets may expand their offerings, creating new opportunities for product innovation and market growth.

Others:

This category includes various unconventional distribution channels for cannabis products, such as specialty shops, farmers' markets, and events. These outlets cater to niche markets and often emphasize artisanal or locally sourced products. The growth of the 'cottage industry' surrounding cannabis products, particularly in regions where legalization is more relaxed, encourages the emergence of unique offerings. Additionally, pop-up shops and cannabis events provide opportunities for direct consumer engagement and education. The diversity of these distribution channels reflects the dynamic nature of the cannabis market and its ability to adapt to consumer preferences and trends.

By Ingredient Type

THC-dominant:

THC-dominant products contain higher levels of tetrahydrocannabinol, the psychoactive compound responsible for the euphoric effects associated with cannabis. This category is particularly popular among recreational users seeking the traditional experience of cannabis consumption. THC-dominant products can include flowers, concentrates, and edibles, providing various consumption methods for users. The demand for these products is bolstered by the burgeoning recreational cannabis market, where consumers are increasingly drawn to the potency and effects of THC. As new strains and products are developed to enhance the consumer experience, the THC-dominant segment is expected to witness continued growth, catering to both seasoned and new consumers alike.

CBD-dominant:

CBD-dominant products are designed to deliver the therapeutic benefits of cannabidiol without the psychoactive effects of THC. This segment has gained notable traction, especially among consumers seeking an alternative for managing anxiety, pain, or inflammation. With the growing body of research supporting the health benefits of CBD, demand for these products is surging. The versatility of CBD allows it to be incorporated into various forms, including oils, edibles, and topicals, making it highly accessible to consumers. Moreover, as more brands focus on creating high-quality, lab-tested CBD products, consumer confidence in CBD-dominant offerings continues to rise, contributing to the segment's expansion.

Balanced THC/CBD:

Balanced THC/CBD products offer consumers the combined benefits of both cannabinoids, providing a more nuanced experience that appeals to a broader audience. These products are particularly attractive to users who seek therapeutic effects without the intensity of pure THC. Balanced formulations allow for customization of effects, enabling consumers to adjust their experience based on personal preferences or specific health needs. The increasing popularity of balanced products reflects a growing understanding of the entourage effect, where the synergistic interaction of various cannabinoids can enhance therapeutic benefits. As market education around this concept continues to spread, the demand for balanced THC/CBD products is expected to grow significantly.

Others:

This category encompasses various cannabis products that do not fit into the traditional THC or CBD-dominant classifications, including those with unique cannabinoid profiles or specialized formulations. These products may include lesser-known cannabinoids such as CBG (cannabigerol) or CBN (cannabinol), each offering distinct potential health benefits. As consumer awareness expands, more companies are likely to explore the development of innovative products that cater to niche markets. Additionally, the rise of personalized cannabis products tailored to individual health needs and preferences is creating opportunities for growth within this segment. The diversification of ingredient types reflects the industry's ongoing evolution and the increasing sophistication of consumer preferences.

By Region

The North American legal cannabis market is the most significant, accounting for a substantial portion of global sales. With countries like Canada legalizing cannabis for both medical and recreational use and numerous states in the U.S. following suit, the region is experiencing rapid growth. The North American market is expected to grow at a CAGR of approximately 27% between 2025 and 2035, driven by increasing consumer acceptance, innovation in product development, and the expansion of retail spaces. Legalization efforts in various states and the growing number of dispensaries contribute to the region's dominance, positioning it as a leader in the global legal cannabis market.

Europe is rapidly emerging as a key player in the legal cannabis market, with countries like Germany and the Netherlands leading the way in medical cannabis legislation. The European market is projected to experience significant growth due to increasing acceptance of cannabis for therapeutic use and the potential for recreational legalization in several countries. As the regulatory landscape evolves, the market is likely to see an influx of new products and distribution channels, catering to the emerging consumer base. Although the current market size is smaller than that of North America, the potential for substantial growth in the coming years positions Europe as a critical region for cannabis market expansion.

Opportunities

The legal cannabis market presents numerous opportunities for businesses and investors looking to capitalize on this rapidly growing sector. One of the most significant opportunities lies in the development of innovative products that cater to diverse consumer preferences. As the market matures, consumers are increasingly seeking unique and specialized cannabis products, including those tailored to specific health needs or lifestyle choices. Companies that invest in research and development to create high-quality, differentiated products stand to gain a competitive advantage. Moreover, partnerships with healthcare providers and wellness brands can further enhance product credibility and reach, expanding market penetration.

Another opportunity exists in the realm of education and advocacy. As more regions consider legalizing cannabis, there is a growing need for increased awareness and understanding of its benefits and responsible use. Companies that prioritize education through workshops, online content, and community engagement initiatives can position themselves as trusted authorities in the industry. This not only fosters consumer loyalty but also contributes to a positive public perception of cannabis. Additionally, as regulations evolve, businesses that stay ahead of compliance requirements will be well-positioned to thrive in an increasingly competitive landscape.

Threats

Despite the significant growth potential of the legal cannabis market, several threats could hinder its progress. One of the primary concerns is the regulatory landscape, which varies widely between regions and can change abruptly. Businesses operating in this sector must navigate complex legal frameworks, which can create barriers to entry and increase operational costs. Moreover, abrupt changes in legislation or inconsistent enforcement can lead to market instability, making it challenging for companies to plan for the future. Additionally, the presence of the illicit cannabis market poses a constant threat to legal operators, as consumers may opt for cheaper, unregulated alternatives that could undermine the growth of the legitimate sector.

Another threat stems from the potential for negative public perception, fueled by historical stigmas associated with cannabis use. As legalization efforts progress, some segments of the population may remain resistant to cannabis, viewing it unfavorably due to past prohibitions. This hesitancy could impact consumer adoption and hinder the growth of the market. Furthermore, potential health risks and safety concerns associated with cannabis consumption, especially regarding overconsumption or unregulated product quality, may deter some consumers. Effective communication and transparency about product safety and efficacy are essential to mitigate these risks and foster consumer confidence.

Competitor Outlook

  • Canopy Growth Corporation
  • Aphria Inc.
  • Tilray Inc.
  • Curaleaf Holdings, Inc.
  • Trulieve Cannabis Corp.
  • Green Thumb Industries Inc.
  • Cresco Labs Inc.
  • Hexo Corp.
  • MedMen Enterprises Inc.
  • Harborside Inc.
  • OrganiGram Holdings Inc.
  • Acreage Holdings, Inc.
  • Charlotte's Web Holdings, Inc.
  • GW Pharmaceuticals
  • Columbia Care Inc.

The competitive landscape of the legal cannabis market is characterized by a mix of established companies and emerging players, each vying for market share in this rapidly evolving industry. Established operators, such as Canopy Growth Corporation and Tilray Inc., have the advantage of extensive resources and brand recognition, enabling them to invest in product development, marketing, and expansive distribution networks. These companies often dominate market segments with a diverse array of products, catering to both recreational and medical cannabis consumers. Moreover, they are also actively pursuing strategic partnerships and acquisitions to bolster their market positions and enhance their portfolios.

On the other hand, smaller and emerging companies, like Trulieve Cannabis Corp. and Green Thumb Industries Inc., are capitalizing on niche markets and localized strategies to differentiate themselves from larger competitors. These companies often focus on quality, artisanal production, and consumer education to build brand loyalty and foster community engagement. Additionally, some of these emerging players are exploring novel distribution channels, such as direct-to-consumer sales and e-commerce platforms, aligning with changing consumer preferences for convenience and accessibility. As competition intensifies, companies in the legal cannabis market must continuously innovate and adapt to maintain their competitive edge.

Companies like Curaleaf Holdings and Harvest Health & Recreation are also making waves in the market, with strong growth trajectories and strategic expansion plans. Their focus on acquiring licenses and establishing dispensaries across multiple states enhances their presence in the highly competitive U.S. cannabis landscape. Furthermore, organizations such as GW Pharmaceuticals are dedicated to research and development, focusing on creating pharmaceutical-grade cannabis products that cater to the medical market. Their commitment to rigorous clinical trials and regulatory compliance sets them apart and positions them for success in the evolving cannabis landscape. Overall, the competitive environment in the legal cannabis market is dynamic, and companies must navigate various challenges to achieve sustained growth.

  • 1 Appendix
    • 1.1 List of Tables
    • 1.2 List of Figures
  • 2 Introduction
    • 2.1 Market Definition
    • 2.2 Scope of the Report
    • 2.3 Study Assumptions
    • 2.4 Base Currency & Forecast Periods
  • 3 Market Dynamics
    • 3.1 Market Growth Factors
    • 3.2 Economic & Global Events
    • 3.3 Innovation Trends
    • 3.4 Supply Chain Analysis
  • 4 Consumer Behavior
    • 4.1 Market Trends
    • 4.2 Pricing Analysis
    • 4.3 Buyer Insights
  • 5 Key Player Profiles
    • 5.1 Hexo Corp.
      • 5.1.1 Business Overview
      • 5.1.2 Products & Services
      • 5.1.3 Financials
      • 5.1.4 Recent Developments
      • 5.1.5 SWOT Analysis
    • 5.2 Aphria Inc.
      • 5.2.1 Business Overview
      • 5.2.2 Products & Services
      • 5.2.3 Financials
      • 5.2.4 Recent Developments
      • 5.2.5 SWOT Analysis
    • 5.3 Tilray Inc.
      • 5.3.1 Business Overview
      • 5.3.2 Products & Services
      • 5.3.3 Financials
      • 5.3.4 Recent Developments
      • 5.3.5 SWOT Analysis
    • 5.4 Harborside Inc.
      • 5.4.1 Business Overview
      • 5.4.2 Products & Services
      • 5.4.3 Financials
      • 5.4.4 Recent Developments
      • 5.4.5 SWOT Analysis
    • 5.5 Cresco Labs Inc.
      • 5.5.1 Business Overview
      • 5.5.2 Products & Services
      • 5.5.3 Financials
      • 5.5.4 Recent Developments
      • 5.5.5 SWOT Analysis
    • 5.6 Columbia Care Inc.
      • 5.6.1 Business Overview
      • 5.6.2 Products & Services
      • 5.6.3 Financials
      • 5.6.4 Recent Developments
      • 5.6.5 SWOT Analysis
    • 5.7 GW Pharmaceuticals
      • 5.7.1 Business Overview
      • 5.7.2 Products & Services
      • 5.7.3 Financials
      • 5.7.4 Recent Developments
      • 5.7.5 SWOT Analysis
    • 5.8 Acreage Holdings, Inc.
      • 5.8.1 Business Overview
      • 5.8.2 Products & Services
      • 5.8.3 Financials
      • 5.8.4 Recent Developments
      • 5.8.5 SWOT Analysis
    • 5.9 Curaleaf Holdings, Inc.
      • 5.9.1 Business Overview
      • 5.9.2 Products & Services
      • 5.9.3 Financials
      • 5.9.4 Recent Developments
      • 5.9.5 SWOT Analysis
    • 5.10 MedMen Enterprises Inc.
      • 5.10.1 Business Overview
      • 5.10.2 Products & Services
      • 5.10.3 Financials
      • 5.10.4 Recent Developments
      • 5.10.5 SWOT Analysis
    • 5.11 Trulieve Cannabis Corp.
      • 5.11.1 Business Overview
      • 5.11.2 Products & Services
      • 5.11.3 Financials
      • 5.11.4 Recent Developments
      • 5.11.5 SWOT Analysis
    • 5.12 OrganiGram Holdings Inc.
      • 5.12.1 Business Overview
      • 5.12.2 Products & Services
      • 5.12.3 Financials
      • 5.12.4 Recent Developments
      • 5.12.5 SWOT Analysis
    • 5.13 Canopy Growth Corporation
      • 5.13.1 Business Overview
      • 5.13.2 Products & Services
      • 5.13.3 Financials
      • 5.13.4 Recent Developments
      • 5.13.5 SWOT Analysis
    • 5.14 Green Thumb Industries Inc.
      • 5.14.1 Business Overview
      • 5.14.2 Products & Services
      • 5.14.3 Financials
      • 5.14.4 Recent Developments
      • 5.14.5 SWOT Analysis
    • 5.15 Charlotte's Web Holdings, Inc.
      • 5.15.1 Business Overview
      • 5.15.2 Products & Services
      • 5.15.3 Financials
      • 5.15.4 Recent Developments
      • 5.15.5 SWOT Analysis
  • 6 Market Segmentation
    • 6.1 Legal Cannabis Market, By Application
      • 6.1.1 Recreational
      • 6.1.2 Medical
    • 6.2 Legal Cannabis Market, By Product Type
      • 6.2.1 Cannabis Flower
      • 6.2.2 Concentrates
      • 6.2.3 Edibles
      • 6.2.4 Topicals
      • 6.2.5 Pre-rolls
    • 6.3 Legal Cannabis Market, By Distribution Channel
      • 6.3.1 Dispensaries
      • 6.3.2 Online Stores
      • 6.3.3 Pharmacies
      • 6.3.4 Supermarkets/Hypermarkets
      • 6.3.5 Others
  • 7 Competitive Analysis
    • 7.1 Key Player Comparison
    • 7.2 Market Share Analysis
    • 7.3 Investment Trends
    • 7.4 SWOT Analysis
  • 8 Research Methodology
    • 8.1 Analysis Design
    • 8.2 Research Phases
    • 8.3 Study Timeline
  • 9 Future Market Outlook
    • 9.1 Growth Forecast
    • 9.2 Market Evolution
  • 10 Geographical Overview
    • 10.1 Europe - Market Analysis
      • 10.1.1 By Country
        • 10.1.1.1 UK
        • 10.1.1.2 France
        • 10.1.1.3 Germany
        • 10.1.1.4 Spain
        • 10.1.1.5 Italy
    • 10.2 Asia Pacific - Market Analysis
      • 10.2.1 By Country
        • 10.2.1.1 India
        • 10.2.1.2 China
        • 10.2.1.3 Japan
        • 10.2.1.4 South Korea
    • 10.3 Latin America - Market Analysis
      • 10.3.1 By Country
        • 10.3.1.1 Brazil
        • 10.3.1.2 Argentina
        • 10.3.1.3 Mexico
    • 10.4 Legal Cannabis Market by Region
    • 10.5 North America - Market Analysis
      • 10.5.1 By Country
        • 10.5.1.1 USA
        • 10.5.1.2 Canada
    • 10.6 Middle East & Africa - Market Analysis
      • 10.6.1 By Country
        • 10.6.1.1 Middle East
        • 10.6.1.2 Africa
  • 11 Global Economic Factors
    • 11.1 Inflation Impact
    • 11.2 Trade Policies
  • 12 Technology & Innovation
    • 12.1 Emerging Technologies
    • 12.2 AI & Digital Trends
    • 12.3 Patent Research
  • 13 Investment & Market Growth
    • 13.1 Funding Trends
    • 13.2 Future Market Projections
  • 14 Market Overview & Key Insights
    • 14.1 Executive Summary
    • 14.2 Key Trends
    • 14.3 Market Challenges
    • 14.4 Regulatory Landscape
Segments Analyzed in the Report
The global Legal Cannabis market is categorized based on
By Product Type
  • Cannabis Flower
  • Concentrates
  • Edibles
  • Topicals
  • Pre-rolls
By Application
  • Recreational
  • Medical
By Distribution Channel
  • Dispensaries
  • Online Stores
  • Pharmacies
  • Supermarkets/Hypermarkets
  • Others
By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Key Players
  • Canopy Growth Corporation
  • Aphria Inc.
  • Tilray Inc.
  • Curaleaf Holdings, Inc.
  • Trulieve Cannabis Corp.
  • Green Thumb Industries Inc.
  • Cresco Labs Inc.
  • Hexo Corp.
  • MedMen Enterprises Inc.
  • Harborside Inc.
  • OrganiGram Holdings Inc.
  • Acreage Holdings, Inc.
  • Charlotte's Web Holdings, Inc.
  • GW Pharmaceuticals
  • Columbia Care Inc.
  • Publish Date : Jan 21 ,2025
  • Report ID : PH-68401
  • No. Of Pages : 100
  • Format : |
  • Ratings : 4.5 (110 Reviews)
Buy Report
Buy Report
Connect With Us
What Our Client Say